| Value | ₹333.4 Cr |
|---|
BSE filing, NSE: ALKEM. Summary written from the filing by ALFA Finder's alert engine.
Alkem Laboratories Ltd: key numbers
- Share price
- ₹5,070.00
- Market cap
- ₹60,619 Cr
- Revenue (annual)
- ₹14,712 Cr
- Net profit (annual)
- ₹2,302 Cr
- P/E (TTM)
- 28.1×Sector 46.1×
- Promoter holding
- 49.70%+0.00% QoQ
- FII holding
- 10.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alkem Laboratories Ltd
All →Alkem Laboratories Legal & Regulatory
Alkem Laboratories has initiated a forensic audit by Grant Thornton Bharat LLP following alleged misappropriation of funds by a former employee.
Alkem Laboratories Other Announcement
Alkem Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements. This document details the company's equity structure.
Alkem Laboratories Management Change
Alkem Laboratories appointed Laxmikant Tiwari and Nilesh Vartak as Senior Management Personnel effective 12 October 2026. The appointments strengthen pharmaceutical operations and supply chain leadership.
Alkem Laboratories Management Change
Alkem Laboratories CFO Nitin Agrawal resigned effective 30 September 2026 for new opportunities. He was also a Key Managerial Personnel of the company.
Alkem Laboratories Debt & Borrowing: ₹593.5 Cr
Alkem Laboratories issued a Corporate Guarantee of Euro 54.45 Million to HSBC UK Bank for a Euro 49.5 Million term loan taken by its subsidiary, Occlutech Holding.
- Value
- ₹593.5 Cr
Alkem Laboratories Product Launch
Alkem launches NeuCeno (cenobamate), an anti-seizure medication for partial-onset seizures in adults, for the first time in India. The once-daily drug is available in six tablet strengths.
Other legal & regulatory announcements
All →Kovai Medical Center and Hospital Legal & Regulatory
Kovai Medical Center received a customs adjudication order for ₹2.11 Crore duty, fine and penalty. The order concerns non-fulfilment of post-importation conditions on duty-free equipment imports.
- Value
- ₹2.11 Cr
SKM Egg Products Export (India) Legal & Regulatory
SKM Egg Products received a Registrar of Companies penalty of about Rs.0.024 Crore for delayed MR-1 filings on director reappointment. The company states no material financial impact.
- Value
- ₹0.02 Cr
Coromandel International Legal & Regulatory
Coromandel International received a Deputy Commissioner (Appeal) GST order-in-appeal for FY 2019-20 confirming ineligible input tax credit demand. The company will appeal before GSTAT and expects no significant financial impact.
- Value
- ₹0.18 Cr
Taurian Mps Legal & Regulatory
Taurian MPS received a SEBI adjudication order imposing penalties of Rs.5 lakh on the company, Rs.5 lakh on promoters jointly, and Rs.8 lakh on the merchant banker. The penalties relate to IPO offer document disclosure deficiencies.
- Value
- ₹0.05 Cr
Coromandel International Legal & Regulatory
Coromandel International received a GST Order-in-Appeal confirming a ₹1.79 Crore tax demand. Including interest and penalty, the total is ₹4.05 Crore; the company will appeal.
- Value
- ₹4.05 Cr
Shreeji Global FMCG Legal & Regulatory
Shreeji Global FMCG received a customs Order-in-Original demanding about ₹42.47 Crore in duty, penalties and redemption fines. The company plans to appeal before CESTAT.
- Value
- ₹42.47 Cr